|
Additive Antinociception Following Co-administration of a NR2B-Selective NMDA Antagonist with BDNF
South, S. M., Dao, C. B., Wyse, B. and Smith, M. T. (2007). Additive Antinociception Following Co-administration of a NR2B-Selective NMDA Antagonist with BDNF. In: 41st Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists, Adelaide, South Australia, (Poster 2 - 72). 2-6 December 2007.
|
|
|
|